$CPIX staging again. profits. $5.28 net revenues were

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$CPIX staging again. profits . $5.28

net revenues
were $9.7 million, up nearly 50% from the prior year period.
Operating cash flow was $4.0 million for the nine months ended
September 30, 2014, as the Company managed expenses in line
with revenue. Cumberland returned to profitability in 2014 with $1.8
million in net income during the first nine months of the year or $0.10
per diluted share.


logo.png
Website

80 % Buy
850318709_barchart_logo1.jpg


Shares Outstanding: 17.36M
Float: 10.77M

% Held by Insiders1 36.94%
% Held by Institutions: 38.50%
Shares Short (as of Nov 28, 2014): 233.02K
Short Ratio (as of Nov 28, 2014): 4.90
Short % of Float (as of Nov 28, 2014): 2.70%
Shares Short (prior month): 232.93K


yahoo_finance_en-US_s_f_p_191x21_finance_2x.png

10-Q 11/7/14
Summary

Recent Trades
599675067_stockwatch.jpg

Headlines

Saturday, November 15, 2014

CUMBERLAND PHARMACEUTICALS INC FinancialsEDGAR Online Financials (Sat, Nov 15)

Sunday, November 9, 2014

10-Q for Cumberland Pharmaceuticals, Inc.Company Spotlight (Sun, Nov 9)

Friday, November 7, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online (Fri, Nov 7)

Tuesday, November 4, 2014

Cumberland Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET todayCCBN (Tue, Nov 4)
Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial ResultsPR Newswire (Tue, Nov 4)
Q3 2014 Cumberland Pharmaceuticals Inc Earnings Release - After Market CloseCCBN (Tue, Nov 4)

Tuesday, October 21, 2014

Cumberland Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 4, 2014PR Newswire (Tue, Oct 21)

Tuesday, October 14, 2014

Caldolor® Safely Treats Fever In Hospitalized ChildrenPR Newswire (Tue, Oct 14)

Friday, October 10, 2014

Caldolor® Provides Favorable Inflammatory Response Results In Laparoscopic Cholecystectomy Surgery PatientsPR Newswire (Fri, Oct 10)

Friday, August 8, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online (Fri, Aug 8)

Tuesday, August 5, 2014

Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial ResultsPR Newswire (Tue, Aug 5)

Tuesday, July 22, 2014

Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014PR Newswire (Tue, Jul 22)

Wednesday, July 2, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a MaterEDGAR Online (Wed, Jul 2)

Monday, May 19, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online (Mon, May 19)

Tuesday, May 13, 2014

Cumberland Pharmaceuticals' (CPIX) CEO A. J. Kazimi on Q1 2014 Results - Earnings Call Transcriptat Seeking Alpha (Tue, May 13)
Cumberland Pharmaceuticals Reports First Quarter 2014 Financial ResultsPR Newswire (Tue, May 13)

Monday, May 12, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, May 12)

Friday, May 9, 2014

CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other EventsEDGAR Online (Fri, May 9)

Wednesday, May 7, 2014

Cumberland Pharmaceuticals Launches Vaprisol® PromotionPR Newswire (Wed, May 7)

Tuesday, May 6, 2014

Cumberland Pharmaceuticals And Gloria Pharmaceuticals Announce Joint Research & Development InvestmentPR Newswire (Tue, May 6)
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Century Communities Expands Home Offerings in Nashville Region

Updated Category News Views 173

Century Communities Expands Home Offerings in Nashville Region Century Communities, Inc.—a prominent national homebuilder known for its innovative approaches in home sales—is excited to announce a significant expansion of its housing offerings in the Nashville area. This growth is indicative of Century’s commitment to meet the increasing demand for quality living...

Continue Reading
Wahl Professional Unveils New KM Series Grooming Clippers

Updated Category News Views 182

Wahl Professional Unveils New KM Series Grooming Clippers Wahl Professional, a leader in the grooming industry, is proud to announce the introduction of two exciting new models in their KM Series tailored for animal grooming. These innovative clippers aim to enhance the grooming experience for professionals and pet owners by simplifying coat maintenance with improved...

Continue Reading
The Reality of Earning as a Veteran at Lockheed Martin

Updated Category News Views 167

A Veteran's Journey in the Defense Industry A skilled defense worker's financial snapshot reveals both the lucrative reality of America's military-industrial complex and the lasting toll of service that no amount of compensation can truly repair. Behind the Numbers: Insights from a Defense Worker The numbers tell one story: A veteran working for Lockheed Martin (NYSE:LMT)...

Continue Reading
Viasat Leader to Speak at Deutsche Bank Space Summit

Updated Category News Views 123

Viasat Announces Key Participation in Global Space Summit Viasat, Inc. (NASDAQ: VSAT), renowned for its leadership in satellite communications, is set to engage in significant discussions at the Deutsche Bank Global Space Summit. The event will feature prominent figures from both commercial and governmental sectors. Viasat's President of Global Space Networks, Craig...

Continue Reading
Rachel Reeves Aims to Revitalize UK Economy with Budget Plan

Updated Category News Views 208

Overview of the Economic Reset British finance minister Rachel Reeves is making significant strides as she approaches her upcoming budget announcement. With this budget, Reeves is looking to smoothly transition the country toward a more favorable economic environment. This initiative is crucial as the Labour Party prepares to take the reins after a long absence from...

Continue Reading